| Victor Hunyadi, DO | |
|
1000 Harrington St, Mount Clemens, MI 48043-2920 | |
| (586) 493-8000 | |
| Not Available |
| Full Name | Victor Hunyadi |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 9 Years |
| Location | 1000 Harrington St, Mount Clemens, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275915092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 5101021555 (Michigan) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 5101021555 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mclaren Macomb | Mount clemens, MI | Hospital |
| Henry Ford Macomb Hospital | Clinton township, MI | Hospital |
| Mclaren Oakland | Pontiac, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mclaren Oakland | 0547173213 | 49 |
| Mclaren Medical Group | 3971416082 | 187 |
| Mclaren Macomb | 8921912791 | 118 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan - a chemical that is produced through the heating process - in certain foods.
When it comes to newborn sleep, mother may not know best. According to Deborah Raines, associate professor in the University at Buffalo School of Nursing, family, cultural and geographical influences may lead some mothers to place their newborn children in unsafe sleeping positions.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
› Verified 5 days ago
| Entity Name | Mclaren Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346396066 PECOS PAC ID: 3971416082 Enrollment ID: O20031106000025 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan - a chemical that is produced through the heating process - in certain foods.
When it comes to newborn sleep, mother may not know best. According to Deborah Raines, associate professor in the University at Buffalo School of Nursing, family, cultural and geographical influences may lead some mothers to place their newborn children in unsafe sleeping positions.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
› Verified 5 days ago
| Entity Name | Mclaren Oakland |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053463778 PECOS PAC ID: 0547173213 Enrollment ID: O20031111000770 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan - a chemical that is produced through the heating process - in certain foods.
When it comes to newborn sleep, mother may not know best. According to Deborah Raines, associate professor in the University at Buffalo School of Nursing, family, cultural and geographical influences may lead some mothers to place their newborn children in unsafe sleeping positions.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
› Verified 5 days ago
| Entity Name | Mclaren Macomb |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396014601 PECOS PAC ID: 8921912791 Enrollment ID: O20040120001000 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan - a chemical that is produced through the heating process - in certain foods.
When it comes to newborn sleep, mother may not know best. According to Deborah Raines, associate professor in the University at Buffalo School of Nursing, family, cultural and geographical influences may lead some mothers to place their newborn children in unsafe sleeping positions.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
› Verified 5 days ago
| Entity Name | Rochester Urgent Care, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316018971 PECOS PAC ID: 2264334564 Enrollment ID: O20040127000012 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan - a chemical that is produced through the heating process - in certain foods.
When it comes to newborn sleep, mother may not know best. According to Deborah Raines, associate professor in the University at Buffalo School of Nursing, family, cultural and geographical influences may lead some mothers to place their newborn children in unsafe sleeping positions.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
› Verified 5 days ago
| Entity Name | Lakeside Urgent Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720159304 PECOS PAC ID: 0446146385 Enrollment ID: O20040226000404 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan - a chemical that is produced through the heating process - in certain foods.
When it comes to newborn sleep, mother may not know best. According to Deborah Raines, associate professor in the University at Buffalo School of Nursing, family, cultural and geographical influences may lead some mothers to place their newborn children in unsafe sleeping positions.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
› Verified 5 days ago
| Entity Name | Inpatient Consultants Of Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861442824 PECOS PAC ID: 6709891286 Enrollment ID: O20060221000260 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan - a chemical that is produced through the heating process - in certain foods.
When it comes to newborn sleep, mother may not know best. According to Deborah Raines, associate professor in the University at Buffalo School of Nursing, family, cultural and geographical influences may lead some mothers to place their newborn children in unsafe sleeping positions.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
› Verified 5 days ago
| Entity Name | Oxford Urgent Care P L C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700036936 PECOS PAC ID: 7214094291 Enrollment ID: O20090318000322 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan - a chemical that is produced through the heating process - in certain foods.
When it comes to newborn sleep, mother may not know best. According to Deborah Raines, associate professor in the University at Buffalo School of Nursing, family, cultural and geographical influences may lead some mothers to place their newborn children in unsafe sleeping positions.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Victor Hunyadi, DO 1000 Harrington St, Mount Clemens, MI 48043-2920 Ph: () - | Victor Hunyadi, DO 1000 Harrington St, Mount Clemens, MI 48043-2920 Ph: (586) 493-8000 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
The Food and Drug Administration today announced that it will embark on a thorough scientific assessment of the health significance of very low levels of furan - a chemical that is produced through the heating process - in certain foods.
When it comes to newborn sleep, mother may not know best. According to Deborah Raines, associate professor in the University at Buffalo School of Nursing, family, cultural and geographical influences may lead some mothers to place their newborn children in unsafe sleeping positions.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
› Verified 5 days ago
Akhlema Paru Haidar, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8142 Fax: 586-493-3250 | |
Dr. Vasudevarao Mandava, M.D Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 18 Market St, Suite C, Mount Clemens, MI 48043 Phone: 586-783-2222 Fax: 586-783-6280 | |
Robert A Chang, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 133 S Main St, Mount Clemens, MI 48043 Phone: 586-468-1600 Fax: 586-465-0329 | |
Jayne Olivia Mitchell, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8000 | |
Misha Kaur Chowdhary, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-3727 | |
Travis Singh Sekhon, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-3727 | |
John Florian Kazmierski, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1030 Harrington St, Suite 101, Mount Clemens, MI 48043 Phone: 586-468-8500 Fax: 586-468-7997 |